Martin D. Berger
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
2017/11/26 by Ryuma Tokunaga, Wu Zhang, Madiha Naseem +8 · 19 citations
Medicine · Immunology and Microbiology · #Chemokine receptors and signaling #Immunotherapy and Immune Responses #Cancer Immunotherapy and Biomarkers